studies conducted over the last decade , and since the drug was previously reviewed in the journal , have confirmed that inhaled beclomethasone dipropionate 400 to 800 micrograms daily can reduce the need for oral maintenance corticosteroids in the majority of asthmatic patients requiring such therapy , and that increasing the dosage to 2000 micrograms daily may provide additional clinical benefit in some patients unresponsive to usual therapeutic dosages .
C0004906
beclomethasone
C0004096
asthmatic